Renol Polychem Ltd IPORNPL

The IPO opens on 31 Jul 2025 & closes on 04 Aug 2025.

Renol Polychem Limited started its operations way back in year 2008 in the name and style of M/s Renol Enterprise, a Partnership Firm and further commenced its operations as a Private Company under the name and style of Renol Polychem Private Limited, since January 09, 2024 with the Registrar of Companies, Ahmedabad. Subsequently, the Company name changed from 'Renol Polychem Private Limited' to 'Renol Polychem Limited' and a Certificate of Incorporation upon the conversion of Company to Public Limited dated June 19, 2024 was issued by the Registrar of Companies, Central Registration Centre. Renol Polychem is a leading chemical company in Rajkot that has continuously achieved growth through relentless challenges and innovation since its establishment in 2008 providing pioneering solutions to help produce UPVC, & CPVC pipes, Pipe fittings and manufacturing plastic products. The material is an all-in-one additive containing stabilisers, internal & external lubricants, impact modifier, color pigments & additional essential chemicals or additives. The Company started manufacturing facility at Rajkot in 2008 and commenced our manufacturing operations in 2020. It specialize in customized master batch quantities to suit the specific requirements of customers. The manufacturing facilities located at Shed Kothariya in Rajkot Gujarat are spread over 4500 Sq. Ft. of area are equipped to carry out end to end manufacturing activities starting from color mixing to production of finished goods. This has a wide range of products which helps in manufacturing various products like UPVC, CPVC, WPC, plastic products. The Company started manufacturing in 2020 by purchasing machinery in July, 2020. After the purchase of machinery, it began manufacturing of Super Pack & One Pack, Anti-Moisture Powder and Colour Pigment in August 2020. After some time, it began manufacturing of Impact Modifier, Processing Aid, and Titanium Dioxide in September 2020. Further, achievement of manufacturing of said products, the Company commenced manufacturing of Filler Granules, Carbon Noodles and Colour Masterbatches in October 2020. The Company launched the IPO of 24,54,000 equity shares of Rs 10 by raising funds aggregating to Rs 25.77 Crore via fresh issue in Aug'25.

Renol Polychem Ltd IPO will close on 04 Aug 2025.

<ul><li>Diversified Product Portfolio Offering offered.</li><li>Strong Client base.</li><li>Experience of our Promoter and core management team.</li><li>Quality Assurance.</li><li>Cost competitiveness and time bound delivery.</li></ul>

<table class="table"> <thead> <tr> <th>S.No</th> <th>Promoters Name</th> <th>Pre Issue Shares</th> <th>Pre Issue Percentage</th> <th>Post Issue Shares</th> <th>Post Issue Percentage</th> </tr> </thead> <tbody> <tr> <td>1</td> <td>Bhaveshbhai Manshukhbhai Harso</td> <td>4093674</td> <td>74.57</td> <td>4093674</td> <td>51.53</td> </tr> <tr> <td>2</td> <td>Naitik Bhaveshbhai Harsoda</td> <td>1395826</td> <td>25.42</td> <td>1395826</td> <td>17.57</td> </tr> <tr> <td>3</td> <td>Hetalben Bhaveshbhai Harsoda</td> <td>100</td> <td>---</td> <td>100</td> <td>---</td> </tr> <tr> <td>4</td> <td>Labhuben Mansukhbhai Harsoda</td> <td>100</td> <td>---</td> <td>100</td> <td>---</td> </tr> </tbody> </table>

<ul><li>Extensive government regulation and the impact of plastics and related on the environment could have a severe impact on its ability to continue the company business operations, which could adversely affect our business, results of operations and financial condition.</li><li>Its continued operations are critical to the company business and any shutdown of its manufacturing unit may adversely affect the company business, results of operations and financial condition.</li><li>In addition to its existing indebtedness for the company existing operations, its may incur further indebtedness during the course of business. the company cannot assure that its would be able to service the company existing and/ or additional indebtedness.</li><li>Substantial portion of its revenues has been dependent upon few clients. The loss of any one or more of the company major clients would have a material effect on its business operations and profitability.</li><li>The Company has experienced negative cash flow in the past and may continue to do so in the future, which could have a material adverse effect on its business, prospects, financial condition, cash flows and results of operations.</li><li>Its Registered Office, manufacturing unit and warehouse(s) are located on rental premises. If the company is unable to renew such rent agreements or relocate on commercially suitable terms, it may have a material adverse effect on its business, results of operation and financial condition.</li><li>Its business is operating under various laws which require it to obtain approvals from the concerned statutory/regulatory authorities in the ordinary course of business and the company inability to obtain, maintain or renew requisite statutory and regulatory permits and approvals for its business operations could materially and adversely affect the company business, prospects, results of operations and financial condition.</li><li>There have been certain instances of non-compliances in respect of ROC filing or payments. Any penalty or action taken by any regulatory authorities in future for non-compliance with provisions of all applicable law and other law could impact on the financial position of the Company to that extent.</li><li>The company derives significant portion of its revenue from sale of limited variety of the company products. An inability to adapt to evolving consumer preferences and demand for particular products, or ensure product quality may adversely impact demand for its products and consequently the company's business, results of operations, financial condition and cash flows.</li><li>The Company does not have long term agreements with suppliers for supply of raw material. Its inability to obtain raw material in a timely manner, in sufficient quantities could adversely affect the company operations, financial condition and/or profitability.</li><li>Under-utilization of its manufacturing capacities and an inability to effectively utilize the company existing manufacturing capacities could have an adverse effect on its business, future prospects and future financial performance.</li><li>Its operations are geographically located in one area i.e. State of Gujarat and any localized social unrest, natural calamities, etc. could have material adverse effect on business and financial operations.</li><li>The company has entered into related party transactions in the past and may continue to do so in the future.</li><li>An increase in the prices of its basic raw material could raise the company manufacturing costs and could adversely affect its profitability.</li><li>Inventories and trade receivables form a major part of its current assets. Failures to manage the company inventory and trade receivables could have an adverse effect on its sales, profitability, cash flow and liquidity. Further the company operations are subject to high working capital requirements. Its inability to maintain sufficient cash flow, credit facilities and other sources of funding, in a timely manner, or at all, to meet requirement of working capital or pay out debts, could adversely affect the company operations.</li><li>The company has certain outstanding litigation against it, an adverse outcome of which may adversely affect its business, reputation and results of operations.</li><li>The Company's logo RENOL A NAME OF TRUST is not registered and is in the process of Registration with Registrar of Trademark; any infringement of its brand name or failures to get it registered may adversely affect the company business.</li><li>If the company is unable to comply with the material covenants of the borrowing or payment of principal or interest payment on borrowing, its business and prospects may be materially and adversely affected.</li><li>The Company is yet to place orders for new machinery. Any delay in placing orders or procurement of such machinery may delay the schedule of implementation and possibly increase the cost of commencing operations.</li><li>Its may faces some delays in implementation of the company proposed objects.</li><li>Its majority of directors does not posses experience of any listed company.</li><li>Its success depends on the company ability to retain and attract qualified management and other key personnel, and if the company is not able to retain them or recruit additional qualified personnel, its may be unable to successfully develop the company business.</li><li>The company generally do business with its customers on purchase order basis and do not enter into long term contracts with most of them.</li><li>The company is subject to the risk of failure of, or a material weakness in, its internal control systems.</li><li>The company has contingent liabilities and capital commitments. Its financial condition could be adversely affected if any of these contingent liabilities or capital commitments materialize.</li><li>Reliance has been placed on information furnished by our certain Director and Key Managerial Personnel for details of their profiles included in this Prospectus.</li><li>Its insurance coverage may not be adequate to protect the company against all potential losses to which its may be subject and this may have a material effect on the company business and financial condition.</li><li>The company has taken guarantees from Promoter & Promoter Group in relation to debt facilities availed by the Company.</li><li>The Company is dependent on third party transportation providers for the delivery of its products and any disruption in their operations or a decrease in the quality of their services could affect the Company's reputation and results of operations.</li><li>Any delay or defaults in receipt of payments or dues from its customers could result in a reduction of the company profits.</li><li>Its may be unable to comply with changes in environmental, health and safety, labour laws and other applicable regulations.</li><li>Its funding requirements and the proposed deployment of Net Proceeds are based on management estimates and the company has not entered into any definitive arrangements to utilize certain portions of the Net Proceeds of the Offer.</li><li>If the company is unable to manage its growth effectively or if its estimates or assumptions used in developing the company strategic plan are inaccurate or its unable to execute the company strategic plan effectively, its business and prospects may be materially and adversely affected.</li><li>Its inability to respond adequately to increased competition from both organized and unorganized players in the market, which may significantly affect the fixation and realisation of the price for its product, which may adversely affect the company business, financial condition and results of operations. The company is subject to competition from both organized and unorganized players in the market, which may significantly affect the fixation and realization of the price for its product, which may adversely affect the company business operation and financial condition.</li><li>Changes in technology may affect its business by making our business capabilities less competitive or obsolete.</li><li>The company is exposed to the risks of significant breaches of data security, and malfunctions or disruptions of information technology systems.</li><li>In addition to normal remuneration, other benefits, and reimbursement of expenses of its Directors (including the company Promoter) and Key Management Personnel are interested in the Company to the extent of their shareholding and dividend entitlement in the Company.</li><li>The Equity Shares have never been publicly traded, and, after the Issue, the Equity Shares may experience price and volume fluctuations, and an active trading market for the Equity Shares may not develop. Further, the price of the Equity Shares may be volatile, and you may be unable to resell the Equity Shares at or above the Issue Price, or at all.</li><li>There is no guarantee that the Equity Shares issued pursuant to the Issue will be listed on the Emerge Platform of NSE in a timely manner or at all.</li><li>There is no monitoring agency appointed by the Company to monitor the utilization of the Issue proceeds.</li><li>Its Promoters and Promoter Group will continue to retain significant control in the Company after the Issue which will allow them to influence the outcome of matters submitted to shareholders for approval. Such a concentration of ownership may also have the effect of delaying, preventing or deterring a change in control.</li><li>Its ability to pay dividends in the future will depends upon future earnings, financial condition, cash flows, working capital requirements and capital expenditures.</li><li>Its employees may engage in misconduct or other improper activities, including non-compliance with regulatory standards and requirements.</li><li>The Issue price of its Equity Shares may not be indicative of the market price of the company Equity Shares after the Issue and the market price of its Equity Shares may decline below the issue price and you may not be able to sell your Equity Shares at or above the Issue Price.</li><li>The objects of the Issue include funding working capital requirements of our Company, which is based on certain assumptions and estimates.</li><li>QIBs and Non-Institutional Bidder are not permitted to withdraw or lower their Bids (in terms of quantity of Equity Shares or the Bid Amount) at any stage after submitting a Bid and Individual Investors are not permitted to withdraw their Bids after Bid/Issue Closing Date.</li><li>The company cannot guarantee the accuracy or completeness of facts and other statistics with respect to India, the Indian economy and industry in which the company operates contained in the Prospectus.</li><li>The company has not identified any alternate source of funding and hence any failures or delay on its part to mobilize the required resources or any shortfall in the Issue proceeds may delay the implementation schedule.</li><li>The average cost of acquisition of Equity Shares by its Promoters, is lower than the Paid up Value of Equity Share.</li><li>The Company may not be successful in penetrating new export markets.</li><li>Its erstwhile firm Renol Enterprises has received GST/ Income Tax notice in the past, an adverse outcome of which may adversely affect the company business, reputation and results of operations.</li><li>The company relies on its in-house team for production of its products. Loss of employee(s) may have an adverse effect on the production of desired quality products which may adversely affect results of the company business operations and financial condition.</li><li>Any further issuance of Equity Shares by the Company or sales of Equity Shares by any significant shareholders may adversely affect the trading price of the Equity Shares.</li></ul>

The Issue type of Renol Polychem Ltd is Book Building - SME.

The minimum application for shares of Renol Polychem Ltd is 2400.

The total shares issue of Renol Polychem Ltd is 2454000.

Initial public issue of upto 24,54,000 equity shares of face value of Rs. 10/- each of Renol Polychem Limited ("RPL" or the "Company" or the "Issuer") for cash at a price of Rs. 105 per equity share including a share premium of Rs. 95 per equity share (the "Issue Price") aggregating to Rs. 25.77 crores ("The Issue"), of which 1,48,800 equity shares of face value of Rs. 10/- each for cash at a price of Rs. 105 per equity share including a share premium of Rs. 95 per equity share aggregating to Rs. 1.56 crores will be reserved for subscription by market maker to the issue (the "Market Maker Reservation Portion"). The public issue less the market maker reservation portion i.e. net issue of 23,05,200 equity shares of face value of Rs. 10/- each at a issue price of Rs. 105 per equity share including a share premium of Rs. 95 per equity share aggregating to Rs. 24.21 crores is herein after referred to as the "Net Issue". The public issue and the net issue will constitute 30.89% and 29.03% respectively of the post issue paid up equity share capital of the company.